HIV Citations List: November, 2016

Literature Citations

1. Computational and Synthetic Approaches for Developing Lavendustin B Derivatives as Allosteric Inhibitors of HIV-1 Integrase. Agharbaoui, F.E., A.C. Hoyte, S. Ferro, R. Gitto, M.R. Buemi, J.R. Fuchs, M. Kvaratskhelia, and L. De Luca. European Journal of Medicinal Chemistry, 2016. 123: p. 673-683. PMID[27517812].
[PubMed]. HIV_11_2016.

2. Analysis of Quinolinequinone Reactivity, Cytotoxicity, and anti-HIV-1 Properties. Alfadhli, A., A. Mack, L. Harper, S. Berk, C. Ritchie, and E. Barklis. Bioorganic & Medicinal Chemistry, 2016. 24(21): p. 5618-5625. PMID[27663546]. PMCID[PMC5065790].
[PubMed]. HIV_11_2016.

3. Amino acid Derivatives. Part 6. Synthesis, in Vitro Antiviral Activity and Molecular Docking Study of New N-alpha-Amino acid Derivatives Conjugated Spacer Phthalimide Backbone. Al-Masoudi, N.A., E. Abood, Z.T. Al-Maliki, W.A. Al-Masoudi, and C. Pannecouque. Medicinal Chemistry Research, 2016. 25(11): p. 2578-2588. ISI[000386763500014].
[WOS]. HIV_11_2016.

4. A Modified P1 Moiety Enhances in Vitro Antiviral Activity against Various Multidrug-resistant HIV-1 Variants and in Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413. Amano, M., P.M. Salcedo-Gomez, R. Zhao, R.S. Yedidi, D. Das, H. Bulut, N.S. Delino, V.R. Sheri, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2016. 60(12): p. 7046-7059. PMID[27620483].
[PubMed]. HIV_11_2016.

5. Anti-HIV-1 Activity of Compounds Derived from Marine Alga Canistrocarpus cervicornis. Barros, C.D., C.C. Cirne-Santos, V. Garrido, I. Barcelos, P.R.S. Stephens, V. Giongo, V.L. Teixeira, and I. Paixao. Journal of Applied Phycology, 2016. 28(4): p. 2523-2527. ISI[000383571300041].
[WOS]. HIV_11_2016.

6. Hydroxytyrosol: A New Class of Microbicide Displaying Broad anti-HIV-1 Activity. Bedoya, L.M., M. Beltran, P. Obregon-Calderon, J. Garcia-Perez, H.E. de la Torre, N. Gonzalez, M. Perez-Olmeda, D. Aunon, L. Capa, E. Gomez-Acebo, and J. Alcami. AIDS, 2016. 30(18): p. 2767-2776. PMID[27677167]. PMCID[PMC5106087].
[PubMed]. HIV_11_2016.

7. An Analog of Camptothecin Inactive against Topoisomerase I is broadly Neutralizing of HIV-1 through Inhibition of Vif-Dependent APOBEC3G Degradation. Bennett, R.P., R.A. Stewart, P.A. Hogan, R.G. Ptak, M.K. Mankowski, T.L. Hartman, R.W. Buckheit, Jr., B.A. Snyder, J.D. Salter, G.A. Morales, and H.C. Smith. Antiviral Research, 2016. 136: p. 51-59. PMID[27825797]. PMCID[PMC5125868].
[PubMed]. HIV_11_2016.

8. GRFT/Carrageenan Gel Inhibits HIV and HSV-2 in Human Cervical Mucosa. Calenda, G., P. Barnable, K. Levendosky, K. Kleinbeck, J.A. Fernandez-Romero, B.O. Keefe, T.M. Zydowsky, and N. Teleshova. AIDS Research and Human Retroviruses, 2016. 32: p. 217-217. ISI[000386774600396].
[WOS]. HIV_11_2016.

9. Design, Synthesis and Evaluation of Small Molecule CD4-Mimics as Entry Inhibitors Possessing Broad Spectrum anti-HIV-1 Activity. Curreli, F., D.S. Belov, R.R. Ramesh, N. Patel, A. Altieri, A.V. Kurkin, and A.K. Debnath. Bioorganic & Medicinal Chemistry, 2016. 24(22): p. 5988-6003. PMID[27707628]. PMCID[PMC5079829].
[PubMed]. HIV_11_2016.

10. Hemoglobin Derived anti-HIV Peptide, HbAHP-25, Restrains HIV-1 Associated Barrier Dysfunction: Potential for Therapeutic Application. Dar, T.B. and K.V.R. Reddy. AIDS Research and Human Retroviruses, 2016. 32: p. 239-239. ISI[000386774600439].
[WOS]. HIV_11_2016.

11. Sennoside A, Derived from the Traditional Chinese Medicine Plant Rheum l., is a New Dual HIV-1 Inhibitor Effective on HIV-1 Replication. Esposito, F., I. Carli, C. Del Vecchio, L. Xu, A. Corona, N. Grandi, D. Piano, E. Maccioni, S. Distinto, C. Parolin, and E. Tramontano. Phytomedicine, 2016. 23(12): p. 1383-1391. PMID[27765358].
[PubMed]. HIV_11_2016.

12. Design of Boronic acid-attributed Carbon Dots on Inhibits HIV-1 Entry. Fahmi, M.Z., W. Sukmayani, S.Q. Khairunisa, A.M. Witaningrum, D.W. Indriati, M.Q.Y. Matondang, J.Y. Chang, T. Kotaki, and M. Kameoka. RSC Advances, 2016. 6(95): p. 92996-93002. ISI[000385389800102].
[WOS]. HIV_11_2016.

13. Preclinical Characterization of a Potent D-Peptide Inhibitor of HIV Entry: Cholesterol-Conjugated PIE12-trimer. Francis, J.N., Y. Nishimura, A. Smith, B. Welch, M. Martin, and M. Kay. AIDS Research and Human Retroviruses, 2016. 32: p. 129-129. ISI[000386774600229].
[WOS]. HIV_11_2016.

14. Characterization of an Oxidation Resistant Griffithsin for Use as an HIV Microbicide. Fuqua, J., K. Hamorsky, L. Wang, L. Kramzer, N. Matoba, L. Rohan, and K. Palmer. AIDS Research and Human Retroviruses, 2016. 32: p. 333-333. ISI[000386774600618].
[WOS]. HIV_11_2016.

15. Dendronized PLGA Nanoparticles with Anionic Carbosilane Dendrons as Antiviral Agents against HIV Infection. Galan, M., C. Fornaguera, P. Ortega, G. Caldero, R. Lorente, J.L. Jimenez, J. de la Mata, M.A. Munoz-Fernandez, C. Solans, and R. Gomez. RSC Advances, 2016. 6(77): p. 73817-73826. ISI[000381490100109].
[WOS]. HIV_11_2016.

16. Novel Quinolone-3-carboxylic acid Derivatives as anti-HIV-1 Agents: Design, Synthesis, and Biological Activities. Hajimahdi, Z., R. Zabihollahi, M.R. Aghasadeghi, S.H. Ashtiani, and A. Zarghi. Medicinal Chemistry Research, 2016. 25(9): p. 1861-1876. ISI[000385175500011].
[WOS]. HIV_11_2016.

17. IQP-0528: The Pharmacokinetics of an anti-HIV NNRTI in Non-human Primates from Various Dosage Forms. Ham, A., P. Srinivasan, L. Pereira, K. Buckheit, A. Martin, T. Singletary, J.N. Zhang, D. Katz, J. Smith, and R. Buckheit. AIDS Research and Human Retroviruses, 2016. 32: p. 116-116. ISI[000386774600208].
[WOS]. HIV_11_2016.

18. Synthesis of Arylated Coumarins by Suzuki-Miyaura Cross-coupling. Reactions and anti-HIV Activity. Hamdy, A.M., Z. Khaddour, N.A. Al-Masoudi, Q. Rahman, C. Hering-Junghans, A. Villinger, and P. Langer. Bioorganic & Medicinal Chemistry, 2016. 24(21): p. 5115-5126. PMID[27647368].
[PubMed]. HIV_11_2016.

19. Therapeutic Potential of Coumarins as Antiviral Agents. Hassan, M.Z., H. Osman, M.A. Ali, and M.J. Ahsan. European Journal of Medicinal Chemistry, 2016. 123: p. 236-255. PMID[27484512].
[PubMed]. HIV_11_2016.

20. Increased Activity of the Entry Inhibitor DS003, a BMS-378806 Analogue, through Binding to the CD4-Induced Epitope in HIV-1 gp120. Herrera, C., S. Harman, P. Rogers, Y. Aldon, N. Armanasco, D. Stieh, J. Holt, J. Nutall, and R.J. Shattock. AIDS Research and Human Retroviruses, 2016. 32: p. 233-233. ISI[000386774600428].
[WOS]. HIV_11_2016.

21. Silk-formulated Antiretrovirals as Candidate Microbicides. Herrera, C., N. Olejniczak, L. Zhang, J. Coburn, D. Kaplan, and P.J. Liwang. AIDS Research and Human Retroviruses, 2016. 32: p. 210-210. ISI[000386774600383].
[WOS]. HIV_11_2016.

22. Vaginal Safety Evaluation of a Triple Antiretroviral Drug-loaded Electrospun Fiber Microbicide in Nonhuman Primates. Jiang, Y.H., D. Patton, Y.C. Sweeney, A. Hajheidari, A. Beyene, R. Stoddard, A. Blakney, E. Roberts, J. Phan, R. Edmark, and K.A. Woodrow. AIDS Research and Human Retroviruses, 2016. 32: p. 115-115. ISI[000386774600206].
[WOS]. HIV_11_2016.

23. Computer-aided Discovery of anti-HIV Agents. Jorgensen, W.L. Bioorganic & Medicinal Chemistry, 2016. 24(20): p. 4768-4778. ISI[000385905800002]. [WOS]. HIV_11_2016.

24. Testing Human anti-HIV Monoclonal Antibodies Produced in Nicotiana for Activity against Cell-associated HIV. Kadasia, K., A. Chung, G. Alter, and D. Anderson. AIDS Research and Human Retroviruses, 2016. 32: p. 138-138. ISI[000386774600243].
[WOS]. HIV_11_2016.

25. Synthesis, Crystal Structure, anti-HIV, and Antiproliferative Activity of New Oxadiazole and Thiazole Analogs. Khan, M.U., S. Hameed, T. Akhtar, N.A. Al-Masoudi, W.A. Al-Masoudi, P.G. Jones, and C. Pannecouque. Medicinal Chemistry Research, 2016. 25(10): p. 2399-2409. ISI[000386697200029].
[WOS]. HIV_11_2016.

26. Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses. Kouokam, J.C., A.B. Lasnik, and K.E. Palmer. Viruses, 2016. 8(311): 16pp. PMID[27869695].
[PubMed]. HIV_11_2016.

27. Asymmetric Synthesis of a Potent HIV-1 Integrase Inhibitor. Kuethe, J.T., G.R. Humphrey, M. Journet, Z. Peng, and K.G. Childers. Journal of Organic Chemistry, 2016. 81(21): p. 10256-10265. PMID[27471910].

[PubMed]. HIV_11_2016.

28. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. Lacombe, B., M. Morel, F. Margottin-Goguet, and B.C. Ramirez. Journal of Virology, 2016. 90(23): p. 10972-10980. PMID[27681137]. PMCID[PMC5110165].

[PubMed]. HIV_11_2016.

29. Anti-HIV-1 ADCC Antibodies Following Latency Reversal and Treatment Interruption. Lee, W.S., T.A. Rasmussen, M. Tolstrup, L. Ostergaard, O.S. Sogaard, M.S. Parsons, and S.J. Kent. AIDS Research and Human Retroviruses, 2016. 32: p. 405-405. ISI[000386774600757].
[WOS]. HIV_11_2016.

30. Hydrophobic-core PEGylated Graft Copolymer-stabilized Nanoparticles Composed of Insoluble Non-Nucleoside Reverse Transcriptase Inhibitors Exhibit Strong anti-HIV Activity. Leporati, A., M.S. Novikov, V.T. Valuev-Elliston, S.P. Korolev, A.L. Khandazhinskaya, S.N. Kochetkov, S. Gupta, J. Goding, E. Bolotin, M.B. Gottikh, and A.A. Bogdanov, Jr. Nanomedicine, 2016. 12(8): p. 2405-2413. PMID[27456163]. PMCID[PMC5116409].
[PubMed]. HIV_11_2016.

31. Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. Leslie, G.J., J. Wang, M.W. Richardson, B.S. Haggarty, K.L. Hua, J. Duong, A.J. Secreto, A.P. Jordon, J. Romano, K.E. Kumar, J.J. DeClercq, P.D. Gregory, C.H. June, M.J. Root, J.L. Riley, M.C. Holmes, and J.A. Hoxie. Plos Pathogens, 2016. 12(11): p. e1005983. PMID[27855210].

[PubMed]. HIV_11_2016.

32. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication. Liu, C., S.G. Dumbre, C. Pannecouque, C.S. Huang, R.G. Ptak, M.G. Murray, S. De Jonghe, and P. Herdewijn. Journal of Medicinal Chemistry, 2016. 59(20): p. 9513-9531. PMID[27748590].
[PubMed]. HIV_11_2016.

33. Lipopolysaccharide Suppresses Human Immunodeficiency Virus 1 Reverse Transcription in Macrophages. Liu, F.L., J.W. Zhu, D. Mu, and Y.T. Zheng. Archives of Virology, 2016. 161(11): p. 3019-3027. PMID[27491414].
[PubMed]. HIV_11_2016.

34. A Lectibody Targeting Env Glycans Exhibits Broad Antiviral Activity against HIV Virions and Infected Cells. Matoba, N., A. Husk, J.C. Kouokam, K. Hamorsky, and T. Grooms. AIDS Research and Human Retroviruses, 2016. 32: p. 237-237. ISI[000386774600436].
[WOS]. HIV_11_2016.

35. Synthesis and Antiviral Properties of New Derivatives of 2-(Alkylsulfanyl)-6-[1-(2,6-difluorophenyl)cyclopropyl]-5-methylpyrimidin-4(3H)-one. Novakov, I.A., A.S. Yablokov, B.S. Orlinson, M.B. Navrotskii, I.A. Kirillov, A.A. Vernigora, A.S. Babushkin, V.V. Kachala, and D. Schols. Russian Journal of Organic Chemistry, 2016. 52(8): p. 1188-1193. ISI[000386779300016].
[WOS]. HIV_11_2016.

36. Surfactant Protein D Inhibits HIV-1 Transfer through Vaginal Explants and Safety Studies Exhibit Broad Therapeutic Index. Pandit, H., H. Yamamoto, T. Fashemi, U. Kishore, T. Madan, and R. Fichorova. AIDS Research and Human Retroviruses, 2016. 32: p. 312-312. ISI[000386774600577].
[WOS]. HIV_11_2016.

37. Deciphering Structure-activity Relationships in a Series of Tat/TAR Inhibitors. Pascale, L., A.L. Gonzalez, A. Di Giorgio, M. Gaysinski, J. Teixido Closa, R.E. Tejedor, S. Azoulay, and N. Patino. Journal of Biomolecular Structure and Dynamics, 2016. 34(11): p. 2327-2338. PMID[26524629].
[PubMed]. HIV_11_2016.

38. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain. Patel, D., J. Antwi, P.C. Koneru, E. Serrao, S. Forli, J.J. Kessl, L. Feng, N. Deng, R.M. Levy, J.R. Fuchs, A.J. Olson, A.N. Engelman, J.D. Bauman, M. Kvaratskhelia, and E. Arnold. Journal of Biological Chemistry, 2016. 291(45): p. 23569-23577. PMID[27645997]. PMCID[PMC5095411].

[PubMed]. HIV_11_2016.

39. Rational Design of Bispecific Antibodies Targeting HIV-1 Env to Achieve Enhanced Anti-viral Potency and Breadth. Steinhardt, J., J. Guenaga, K. McKee, M. Louder, S. O'Dell, C.I. Chiang, L. Lei, N. Doria-Rose, J. Mascola, and Y.X. Li. AIDS Research and Human Retroviruses, 2016. 32: p. 90-90. ISI[000386774600158].

[WOS]. HIV_11_2016.

40. Design, Synthesis and Biological Evaluation of Caffeoyl benzanilides as Dual Inhibitors of HIV Integrase and CCR5. Sun, X.F., N.N. Fan, W.S. Xu, Y.X. Sun, X. Xie, Y. Guo, L.Y. Ma, J.Y. Liu, and X.W. Wang. MedChemComm, 2016. 7(10): p. 2028-2032. ISI[000386218100018].
[WOS]. HIV_11_2016.

41. Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Tsiang, M., G.S. Jones, J. Goldsmith, A. Mulato, D. Hansen, E. Kan, L. Tsai, R.A. Bam, G. Stepan, K.M. Stray, A. Niedziela-Majka, S.R. Yant, H. Yu, G. Kukolj, T. Cihlar, S.E. Lazerwith, K.L. White, and H. Jin. Antimicrobial Agents and Chemotherapy, 2016. 60(12): p. 7086-7097. PMID[27645238].
[PubMed]. HIV_11_2016.

42. A Chimeric Human APOBEC3A Protein with a Three Amino acid Insertion Confers Differential HIV-1 and Adeno-associated Virus Restriction. Wang, Y.Q., Z.K. Wang, A. Pramanik, M.L. Santiago, J.M. Qiu, and E.B. Stephens. Virology, 2016. 498: p. 149-163. PMID[27584592].
[PubMed]. HIV_11_2016.

43. Annexin A2 Antibodies but Not Inhibitors of the Annexin A2 Heterotetramer Impair Productive HIV-1 Infection of Macrophages in Vitro. Woodham, A.W., A.M. Sanna, J.R. Taylor, J.G. Skeate, D.M. Da Silva, L.V. Dekker, and W.M. Kast. Virology Journal, 2016. 13(1): p. 187. PMID[27863502]. PMCID[PMC5116172].
[PubMed]. HIV_11_2016.

44. 2,4,5-Trisubstituted Thiazole Derivatives as HIV-1 NNRTIs Effective on Both Wild-type and Mutant HIV-1 Reverse Transcriptase: Optimization of the Substitution of Positions 4 and 5. Xu, Z., J. Guo, Y. Yang, M. Zhang, M. Ba, Z. Li, Y. Cao, R. He, M. Yu, H. Zhou, X. Li, X. Huang, Y. Guo, and C. Guo. European Journal of Medicinal Chemistry, 2016. 123: p. 309-316. PMID[27484516].
[PubMed]. HIV_11_2016.

45. Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-type and Bevirimat-resistant HIV-1. Zhao, Y., Q. Gu, S.L. Morris-Natschke, C.H. Chen, and K.H. Lee. Journal of Medicinal Chemistry, 2016. 59(19): p. 9262-9268. PubMed[27676157].
[PubMed]. HIV_11_2016.

Patent Citations

46. Preparation of 2-Styrylcyclopropan-1-amine Derivatives as LSD1 Inhibitors and Uses Thereof. Albrecht, B.K., J.E. Audia, A. Cote, M. Duplessis, V.S. Gehling, J.-C. Harmange, and R.G. Vaswani. Patent. 2016. 2016-US28864 2016172496: 274pp.

[Patent]. HIV_11_2016.

47. Preparation of Sulfonylureas as Inhibitors of Human Immunodeficiency Virus Replication. Bender, J.A., R.G. Gentles, A. Pendri, A.X. Wang, N.A. Meanwell, B.R. Beno, R.A. Fridell, M. Belema, V.N. Nguyen, Z. Yang, G. Wang, S. Kumaravel, S. Thangathirupathy, R.O. Bora, S.M. Holehatti, M.R. Mettu, and M. Panda. Patent. 2016. 2016-US28762 2016172424: 319pp.

[Patent]. HIV_11_2016.

48. Preparation of bis(Amino Acid) Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Use for the Treatment of HIV Infection. Bender, J.A., O.D. Lopez, V.N. Nguyen, Z. Yang, A.X. Wang, G. Wang, N.A. Meanwell, B.R. Beno, R.A. Fridell, M. Belema, and S. Thangathirupathy. Patent. 2016. 2016-US28763 2016172425: 350pp.

[Patent]. HIV_11_2016.

49. Inhibitors of Viruses. Golden, J.E. and D. Chung. Patent. 2016. 2016-US31662 2016183093: 78pp.

[Patent]. HIV_11_2016.

50. Preparation of Novel C-3 Triterpenones with C-28 Reverse Amide Derivatives as HIV Inhibitors. Reddy, B.P., G.L.D. Krupadanam, A.P. Reddy, K.B. Reddy, L.V.L. Subrahmanyam, and K.R. Reddy. Patent. 2016. 2016-IB811 2016178092: 148pp.

[Patent]. HIV_11_2016.

51. Oligomer Modified Diaromatic Substituted Compounds. Riggs-Sauthier, J. and B.-L. Deng. Patent. 2016. 2012-13580580 9226970.

[Patent]. HIV_11_2016.